Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers in Dresden succeed a break-through in diabetes therapy utilizing artificial pancreas

29.10.2013
Human beta cells of the islets of Langerhans utilized in a bio-reactor implant produced reliably insulin in a type 1 diabetes patient for a whole year - for the first time, researcher at the University Hospital Carl Gustav Carus Dresden, have demonstrated an artificial pancreas system. The implant restored the physiological function of insulin production in a type 1 diabetes patient.

The team of Professor Dr Stefan R. Bornstein, Director of the Department of Medicine III in Dresden, implanted the bio-reactor in a patient. The results of the first year are now published in the Journal of Proceedings of the National Academy of Sciences (PNAS 2013; doi:10.1073/pnas.1317561110).

The novel approach has the potential to replace the transplantation with subsequent immunosuppression. However, more research and a broader study is necessary before a large number of type 1 diabetes patients could benefit from this findings.

For the very first time ever, a patient with type 1 diabetes got an artificial pancreas system implanted which produces vital insulin in islet cells like in the pancreas. The small bio-reactor which looks like a little tin has been in the patient body for about one year. The artificial system which has been developed by an Israeli company supersedes an immunosuppression completely. The donor cells will be protected against immune system responses of the patient.

In reverse the insulin will be released into the body. Prof Bornstein, Director of the Department of Medicine III at the University Hospital: “The controlled supply of the cells with oxygen is vital to keep them alive.” He is convinced that the new system shall revolutionise the therapy of diabetes. Many more patients with diabetes type 1 will benefit from a transplantation of islet cells because the recipients do not need any immunosuppressive drugs for their lifetime.

„This is further proof of 20 years successful alliance of medical research and care in Dresden”, says Prof. Michael Albrecht, Medical Manager of the University Hospital Carl Gustav Carus. “This impressive result shows our demand implementing basic research in favour of our patients – the primary objective of the Medical Faculty in Dresden”, says Prof Dr Heinz Reichmann, dean of Medical Faculty Carl Gustav Carus of Technical University Dresden.

Nobel medicine winner Prof Andrew V. Schally of Miller School of Medicine at the University of Miami, who has a research collaboration with Dresden, pronounced “This is a success of historical meaning“. Despite medication, some patients with type 1 diabetes suffer of life threatening deviation of their glucose balance. Transplantation of pancreas as well as islet cells are the only two options to replace insulin producing beta cells and restore the physiological function of insulin production. Both options mean a considerably better control of diabetes and quality of life for the patient. However, the permanent taking of immunosuppressive drugs makes patients susceptible for infections and other adverse effects like a higher risk of cancer. Therefore, these treatments were considered for patients with special medical requirements only.

Dr Barbara Ludwig started the program of transplantation of human beta cells of the islets of Langerhans in 2008. It is the first and only centre of its kind in Germany. The main interest of Dr Ludwig’s group is the quality improvement of human beta cell transplantations. The artificial pancreas system was intensively tested in animals with the colleagues from Israel. The result of this cooperation project was recently published in Proceedings of the National Academy of Sciences (PNAS 2013; doi:10.1073/pnas.1317561110).

Surely, more work has to be done, but Prof Bornstein is certain that the new system will be a serious option in therapy of diabetes in five years time.

Contact:
University Hospital Carl Gustav Carus Dresden
Technical University Dresden
Department of Medicine III
Prof Dr Stefan R. Bornstein
Tel.: +49 351 458 5955
Fax: +49 351 458 6398
E-Mail: stefan.bornstein@uniklinkum-dresden.de

Susanne Witzigmann | idw
Further information:
http://www.uniklinkum-dresden.de

More articles from Health and Medicine:

nachricht Study tracks inner workings of the brain with new biosensor
16.08.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Foods of the future
15.08.2018 | Georg-August-Universität Göttingen

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: It’s All in the Mix: Jülich Researchers are Developing Fast-Charging Solid-State Batteries

There are currently great hopes for solid-state batteries. They contain no liquid parts that could leak or catch fire. For this reason, they do not require cooling and are considered to be much safer, more reliable, and longer lasting than traditional lithium-ion batteries. Jülich scientists have now introduced a new concept that allows currents up to ten times greater during charging and discharging than previously described in the literature. The improvement was achieved by a “clever” choice of materials with a focus on consistently good compatibility. All components were made from phosphate compounds, which are well matched both chemically and mechanically.

The low current is considered one of the biggest hurdles in the development of solid-state batteries. It is the reason why the batteries take a relatively long...

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Air pollution leads to cardiovascular diseases

21.08.2018 | Ecology, The Environment and Conservation

Researchers target protein that protects bacteria's DNA 'recipes'

21.08.2018 | Life Sciences

A paper battery powered by bacteria

21.08.2018 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>